Episode Player

Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure

The Lancet HIV in conversation with

The Lancet HIV in conversation with
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
Feb 04, 2025
The Lancet Group

Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.

Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv